Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950170-25-051604
Filing Date
2025-04-07
Accepted
2025-04-07 16:20:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 10933
  Complete submission text file 0000950170-25-051604.txt   12807
Mailing Address 490 ARSENAL WAY SUITE 210 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 210 WATERTOWN MA 02472 (339) 666-3320
Tectonic Therapeutic, Inc. (Subject) CIK: 0001681087 (see all company filings)

EIN.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-90532 | Film No.: 25818382
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 40 BROAD STREET, SUITE 201 BOSTON MA 02109
Business Address 40 BROAD STREET, SUITE 201 BOSTON MA 02109 857-254-9492
Vida Ventures II, LLC (Filed by) CIK: 0001776851 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A